Here are supplementary biomarkers related to the Aβ signaling pathway: LDL receptor-related protein 1 (LRP1) is another CSF and blood biomarker that has the potential to differentiate two stages of AD classified as MCI and late-stage-AD. This evidence concerns the gene LRP1 and Alzheimer disease.